US drug-maker Gilead Sciences inks pact with 3 Indian drugmakers to produce, sell Remdesivir
New Delhi: US drug-maker Gilead Sciences has signed non-exclusive voluntary licensing agreements with three Indian pharmaceutical companies -- Mumbai-headquartered Cipla, Hyderabad-based...